Advertisement

Picture Kentro Design Corporate and Web Design for Start Ups 2x 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 2572 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures 2022-06-22
ProtonDx–SciTribe: public relations, 202206 service existent by SciTribe 2022-06-21
Spirea–ACF Investors: investment, 202206 financing round totalling £2.4m incl co-investor ACF Investors 2022-06-14
Spirea–Cambridge Angels: investment, 202206 financing round totalling £2.4m incl co-investor Cambridge Angels 2022-06-14
Spirea–Meltwind: investment, 202206 financing round totalling £2.4m incl existing + co-lead investor Jonathan Milner 2022-06-14
Spirea–o2h: investment, 202206 financing round totalling £2.4m incl existing + co-investor o2h Ventures 2022-06-14
Spirea–R42 Group: investment, 202206 financing round totalling £2.4m incl co-investor R42 Group 2022-06-14
Spirea–SEVERAL: investment, 202206 financing round £2.4m led by Jonathan Milner + Cambridge Enterprise 2022-06-14
Spirea–SyndicateRoom: investment, 202206 financing round totalling £2.4m incl existing + co-investor Syndicate Room 2022-06-14
Spirea–Univ Cambridge: investment, 202206 financing round totalling £2.4m incl existing + co-lead investor Cambridge Enterprise 2022-06-14
Charm Therapeutics–Axial: investment, 202206 financing round Series A totalling $50m incl co-investor Axial 2022-06-09
Charm Therapeutics–Braavos Investment Advisers: investment, 202206 financing round Series A totalling $50m incl co-investor Braavos 2022-06-09
Charm Therapeutics–Consilium: public relations, 202206 service existent by Consilium Strategic Communications 2022-06-09
Charm Therapeutics–F-Prime: investment, 202206 financing round Series A totalling $50m incl co-lead investor F-Prime Capital 2022-06-09
Charm Therapeutics–General Catalyst: investment, 202206 financing round Series A totalling $50m incl co-investor General Catalyst 2022-06-09
Charm Therapeutics–Khosla Ventures: investment, 202206 financing round Series A totalling $50m incl co-investor Khosla Ventures 2022-06-09
Charm Therapeutics–OrbiMed: investment, 202206 financing round Series A totalling $50m incl co-lead investor OrbiMed 2022-06-09
Charm Therapeutics–SEVERAL: investment, 202206 financing round Series A $50m co-led by F-Prime Capital + OrbiMed 2022-06-09
Forbion–SEVERAL: investment, 202206 first close €470m of Forbion Growth Opportunities Fund II with target size of €600m hard cap 2022-06-09
Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners 2022-06-09
Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital 2022-06-09
Peptone–Hoxton Ventures: investment, 202206 financing round Series A totalling $40m incl existing + co-investor Hoxton Ventures 2022-06-09
Peptone–Novartis: investment, 202206 financing round Series A totalling $40m incl existing + co-investor dRX Capital 2022-06-09
Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine 2022-06-09
Peptone–SEVERAL: investment, 202206 financing round Series A $40m led by F-Prime + Bessemer Venture Partners 2022-06-09
Peptone–Walden Catalyst: investment, 202206 financing round Series A totalling $40m incl co-investor Walden Catalyst Vemtures 2022-06-09
Relation Therapeutics–SEVERAL: investment, 202206 seed financing round $25m co-led by DCVC + Magentic Ventures 2022-06-09
Synklino–Optimum Strategic Communications: public relations, 202206 service existent by Optimum 2022-06-08
ImmunOs Therapeutics–SEVERAL: investment, 202206 financing round Series B $74m led by Samsara BioCapital + Lightspeed VP + Gimv 2022-06-07
Transition Bio–SEVERAL: investment, 202206 financing round Series A $50m led by Northpond Ventures 2022-06-02
Affinivax–GSK: investment, 202205– acquisition 100% for $2.1b upfront + $1.2b milestones by GSK ANNOUNCED 2022-05-31
Transine Therapeutics–Epidarex Capital: investment, 202205 seed financing round expansion totalling £4.6m incl new + lead investor Epidarex 2022-05-31
Transine Therapeutics–SEVERAL: investment, 202205 seed financing round expansion £4.6m led by Epidarex bringing total seed round to £13.7m 2022-05-31
Transine Therapeutics–SV Health Investors: investment, 202205 seed financing round expansion totalling £4.6m incl existing + co-investor DDF 2022-05-31
Advent Life Sciences–Scius Communications: public relations, 202205 supply service existent by Scius Communications 2022-05-26
uMotif–Athyrium Capital: investment, 202205 investment $25.5m from fund managed by Athyrium Capital Management LP 2022-05-25
Elasmogen–BGF (GB): investment, 202205 financing round totalling £8m incl co-lead investor BGF 2022-05-18
Elasmogen–Deepbridge Capital: investment, 202205 existent Deepbridge Capital is existing investor 2022-05-18
Elasmogen–Scotland (govt): investment, 202205 financing round totalling £8m incl existing + co-investor Scottish Enterprise 2022-05-18
Elasmogen–Scotland (govt): investment, 202205 financing round totalling £8m incl £3.5m from co-lead investor Scottish National Investment Bank 2022-05-18
Elasmogen–SEVERAL: investment, 202205 financing round £8m led by BGF + Scottish National Investment Bank 2022-05-18
SwanBio Therapeutics–SEVERAL: investment, 202205 financing round Series B $56m led by founding investors Syncona Ltd + Mass General Brigham Ventures 2022-05-18
SwanBio Therapeutics–Syncona: investment, 202205 financing round Series B totalling $56m incl existing + co-lead investor Syncona Ltd 2022-05-18
Apollo Global Management–Sofinnova: life science financing, 202205– strategic partnership incl investm in Sofinnova Partners + up to $1b capital 2022-05-16
HH2E–Foresight Group: investment, 202205 financing round totalling at least €12m incl Foresight Group acquiring minority share 2022-05-16
HH2E–HydrogenOne Capital: investment, 202205 financing round totalling at least €12m incl HydrogenOne Capital acquiring minority share 2022-05-16
HH2E–SEVERAL: investment, 202205 financing round at least €12m with HydrogenOne Capital + Foresight Group aquiring minoirty stakes ANNOUNCED 2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– acquisition of minority equity interest in Sofinnova Partners as part of strategic partnership 2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– commitment of up to $1b managed capital to Sofinnova Partners investment funds by Apollo 2022-05-16
Artax Biopharma–Advent Life Sciences: investment, 202205 financing round totalling $26m incl existing investor Advent Life Sciences 2022-05-11
Artax Biopharma–SEVERAL: investment, 202205 financing round $26m with new investors Eli Lilly + Sound Bioventures et al 2022-05-11
Domain Therapeutics–Schroders: investment, 202205 financing round Series A totalling €39m incl co-investor Schroders Capital 2022-05-10
Domain Therapeutics–SEVERAL: investment, 202205 financing round Series A €39m co-led by Panacea Venture + CTI Life Sciences + 3B Future Health Fund 2022-05-10
VisusNano–Discovery Park: investment, –202205– financing round Series A totalling £1.5m incl £100k from Discovery Park Ventures 2022-05-09
VisusNano–SEVERAL: investment, –202205– financing round Series A £1.5m expected to close shortly 2022-05-09
VisusNano–United Kingdom (govt): grant, 202205c Innovate UK Biomedical Catalyst award £1.39m 2022-05-09
Vitarka Therapeutics–Discovery Park: investment, 202205 seed financing round totalling £150k incl £140k from Discovery Park Ventures 2022-05-09
Vitarka Therapeutics–SEVERAL: investment, 202205 seed financing round £150k led by Discovery Park Ventures with £140k 2022-05-09
Sidekick Health–Asabys Partners: investment, 202205 financing round Series B totalling $55m incl co-investor Asabys Partners 2022-05-05
Sidekick Health–Frumtak Ventures: investment, 202205 financing round Series B totalling $55m incl co-investor Frumtak Ventures 2022-05-05
Sidekick Health–Novator Partners: investment, 202205 financing round Series B totalling $55m incl existing + lead investor Novator Ventures 2022-05-05
Sidekick Health–OTHER: investment, 202205 financing round Series B totalling $55m incl co-investor undisclosed US-based strategic investor 2022-05-05
Sidekick Health–SEVERAL: investment, 202205 financing round Series B $55m led by Novator Ventures 2022-05-05
Sidekick Health–Wellington Partners: investment, 202205 financing round Series B totalling $55m incl existing + co-investor Wellington Partners 2022-05-05
OMass–SEVERAL: investment, 202204 financing round Series B £75.5m led by new investors GV + Northpond Ventures + Sanofi Ventures 2022-04-28
Peak Proteins–Sygnature Discovery: investment, 202204 acquisition €na of Peak Proteins by Sygnature Discovery 2022-04-26
MitoRx Therapeutics–SEVERAL: investment, 202204 seed financing round €na incl UKI2S + Wren Capital + Longevitytech.fund et al 2022-04-25
Ramarketing–NorthEdge Capital: investment, 202204 investment by NorthEdge SME Fund I to finance expansion of services + US presence 2022-04-20
BioCaptiva–Huntsworth: public relations, 202204 service existent by Medistrava Consulting 2022-04-13
Sierra Oncology–GSK: investment, 202204– acquisition $1.9b in cash at $55/share of common stock ANNOUNCED 2022-04-13
Terumo–Image Box: public relations, 202204 service existent for Terumo Blood and Cell Technologies by Image Box Communications 2022-04-13
Abingworth–Carlyle: investment, 202204– acquisition €na of Abingworth by Carlyle ANNOUNCED 2022-04-11
Axol Bioscience–Calculus Capital: investment, 202204 financing round extension totalling £3.2m incl existing + co-lead investor Calculus Capital 2022-04-07
Axol Bioscience–Meltwind: investment, 202204 financing round extension totalling £3.2m incl co-investor Scottish Enterprise Meltwind 2022-04-07
Axol Bioscience–Par Equity: investment, 202204 financing round extension totalling £3.2m incl existing + co-lead investor Par Equity 2022-04-07
Axol Bioscience–Scotland (govt): investment, 202204 financing round extension totalling £3.2m incl existing + co-lead investor Scottish Enterprise 2022-04-07
Axol Bioscience–SEVERAL: investment, 202204 extension of financing round of 3/21 £3.2m bringing total round to £7m 2022-04-07
Kynos Therapeutics–SEVERAL: investment, 202204 initial VC financing round £6.5m led by Epidarex Capital with IP Group + Scottish Enterprise 2022-04-07
Kynos Therapeutics–United Kingdom (govt): grant, 202204 Innovate UK grant £2.5m for phase 1 study of lead KMO inhibitor 2022-04-07
ReViral–Pfizer: investment, 202204– acquisition up to $525m of ReViral by Pfizer 2022-04-07
Avi Medical–Balderton Capital: investment, 202204 financing round Serise B totalling €50m incl lead investor Balderton Capital 2022-04-06
Avi Medical–SEVERAL: investment, 202204 financing round Series B €50m led by Balderton Capital 2022-04-06
United KIngdom (govt)–Catalent: investment, 202204 acquisition of VMIC Ltd a development + production facility under construction in Oxford 2022-04-06
Optimal Industrial–Bruker: investment, 202204 acquisition €na of Optimal Industrial Automation + Technologies by Bruker 2022-04-05
Labster–SEVERAL: investment, 202204 financing round Series C 2nd tranche $47m bringing total Series C to $107m 2022-04-04
Rapid Genomics–LGC: investment, 202204 acquisition of Rapid Genomics by LGC 2022-04-01
Abzena–Biospring Partners: investment, 202203 financing round totalling $65m incl existing investor Biospring Partners 2022-03-31
Abzena–SEVERAL: investment, 202203 financing round $65m from majority owner WCAS with Biospring Partners + affilaited investors 2022-03-31
Abzena–Welsh Carson Anderson & Stowe: investment, 202203 financing round totalling $65m incl majority owner WCAS 2022-03-31
Axa–Canary Wharf Group: real estate, 202203– collab joint venture of Kadans Science Partner + CWG to built wet lab buliding in Canary Wharf London 2022-03-30
VectivBio–Kreos Capital: credit, 202203– loan facility up to $75m with minimum draw down of $10m 2022-03-30
Core Biogenesis–Blue Horizon Ventures: investment, 202203 financing round Series A totalling €10m incl new + co-lead investor Blue Horizon Ventures 2022-03-29
Core Biogenesis–Entrepreneur First: investment, 202203 financing round Series A totalling €10m incl existing + co-investor Entrepreur First 2022-03-29
Core Biogenesis–SEVERAL: investment, 202203 financing round Series A €10m led by XAnge + Blue Horizon Ventures 2022-03-29
Core Biogenesis–Siparex: investment, 202203 financing round Series A totalling €10m incl existing + co-lead investor XAnge 2022-03-29
Sano Genetics–MMC Ventures: investment, 202203 financing round Series A totalling $11m incl lead investor MMC Ventures 2022-03-28
Sano Genetics–SEVERAL: investment, 202203 financing round Series A $11m led by MMC Ventures 2022-03-28
Gilde Investment–SEVERAL: investment, 202203 first + final close of €517m Gilde Healthcare Private Equity IV fund 2022-03-16
Precirix–SEVERAL: investment, 202203 financing round Series B €80 co-led by new investors Inkef Capital + Jeito Capital + Forbion 2022-03-16
SeaBeLife–Andrew Lloyd Associates: public relations, 202203 service existent by ALA 2022-03-14
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26  next pagenext page



Advertisement

Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top